We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

128 hedge funds and large institutions have $904M invested in Sarepta Therapeutics in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

39% less call options, than puts

Call options by funds: $120M | Put options by funds: $196M

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$120M
Puts
$196M
Net Calls
-$75.6M
Net Calls Change
-$75.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$104M +$97.3M +2,722,088 New
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$86.5M +$81.3M +2,272,043 New
CWAM
3
Columbia Wanger Asset Management
Illinois
$68M +$63.9M +1,787,000 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$61.1M +$57.5M +1,606,996 New
BFA
5
BlackRock Fund Advisors
California
$38.7M +$36.4M +1,017,593 New
State Street
6
State Street
Massachusetts
$36.4M +$34.2M +957,437 New
GGHC
7
Gilder Gagnon Howe & Co
New York
$35.2M +$33.1M +926,528 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$33.3M +$31.3M +874,248 New
Fidelity Investments
9
Fidelity Investments
Massachusetts
$32.6M +$30.7M +857,262 New
BIT
10
BlackRock Institutional Trust
California
$32.5M +$30.6M +855,128 New
Viking Global Investors
11
Viking Global Investors
Connecticut
$25.4M +$23.9M +668,175 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$22.4M +$21.1M +589,977 New
SM
13
Sabby Management
Florida
$17.3M +$16.3M +454,899 New
Barclays
14
Barclays
United Kingdom
$17M +$16M +447,216 New
JG
15
Jefferies Group
New York
$16.3M +$15.4M +429,739 New
SFM
16
Soros Fund Management
New York
$16.2M +$15.2M +425,689 New
EA
17
Emerald Advisers
Pennsylvania
$16M +$15.1M +421,621 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$15.3M +$14.4M +402,375 New
Wellington Management Group
19
Wellington Management Group
Massachusetts
$15.1M +$14.2M +396,028 New
GIM
20
Granahan Investment Management
Massachusetts
$13.2M +$12.4M +346,840 New
OAM
21
Oxford Asset Management
United Kingdom
$11M +$10.3M +288,410 New
AllianceBernstein
22
AllianceBernstein
Tennessee
$10.6M +$10M +279,802 New
TI
23
Turner Investments
Pennsylvania
$9.28M +$8.73M +243,980 New
Ameriprise
24
Ameriprise
Minnesota
$9.07M +$8.52M +238,298 New
RCM
25
Raptor Capital Management
Massachusetts
$8.76M +$8.23M +230,200 New
1
2 3 4 5

SRPT Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q2 2013, worth a combined $904M.

Buyers outnumbered sellers: 128 funds opened new SRPT positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Sarepta Therapeutics (SRPT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $904M of Sarepta Therapeutics stock for Q2 2013.
  • 128 funds opened new Sarepta Therapeutics positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.